- Home
- MIST vs ETON Comparison
MIST vs ETON Comparison
Compare MIST & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | ETON |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 411.9M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MIST | ETON |
|---|---|---|
| Price | $1.68 | $18.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $8.50 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 1.3M | 291.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $39,011,000.00 |
| Revenue This Year | N/A | $107.23 |
| Revenue Next Year | N/A | $29.72 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 23.29 |
| 52 Week Low | $0.63 | $11.09 |
| 52 Week High | $3.06 | $23.00 |
Technical Indicators
Market Signals| Indicator | MIST | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 44.90 | 64.96 |
| Support Level | $1.62 | $16.04 |
| Resistance Level | $1.79 | $20.01 |
| Average True Range (ATR) | 0.08 | 1.08 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 59.62 | 70.56 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.